Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it’s commercialized several products.

Vertex Pharmaceuticals Inc. closed 8.54% short of its 52-week high of $519.88, which the company achieved on November 8th.

The opioid crisis has claimed the lives of over half a million Americans since the beginning of the epidemic, a process ...

Global drugmakers and MedTech companies bounced back after U.S. President Donald Trump issued a 90-day pause on reciprocal ...

Shares in many large drugmakers initially fell Wednesday on the president's threat, only to rebound later when he announced a ...

Three homers was a recipe for success for the 2024 Nationals, but Friday night the blasts couldn’t halt a 6-4 loss to Arizona, Washington’s fourth straight. The Nationals placed Soroka on the ...

Vertex’s effort to provide fertility support services to those on government insurance programs who want to take the ...

Elo Mutual Pension Insurance trimmed its stake in Vertex Pharmaceuticals by 4% in Q4, now holding $9.49 million in shares. Several other institutional investors also made notable adjustments, with ...

Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.

With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...